Market Research Logo

Serbia Pharmaceuticals & Healthcare Q1 2018

Serbia Pharmaceuticals & Healthcare Q1 2018

BMI View: Serbia's low per capita pharmaceutical expenditure highlights the weak demand for high-value medicines in the country. Poor access to healthcare services, weak intellectual property protection and the government's continued austerity measures create a challenging environment for innovative drugmakers. Although we expect the market growth to accelerate in the coming years, it will underperform by regional standards and remain highly unattractive to multinational pharmaceutical investment.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Serbia 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Serbia 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Serbia 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Serbia 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Serbia 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Serbia 2013-2021)
OTC Medicine Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Serbia 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Serbia 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Serbia 2015-2021)
Industry Risk/Reward Index
Europe - Central And Eastern Europe Pharmaceuticals: Most Attractive Emerging Market
Regulatory Review
Intellectual Property Environment
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Serbia 2011-2016)
Table: Healthcare Personnel (Serbia 2011-2016)
Table: Healthcare Activity (Serbia 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Serbia Pharmaceuticals & Healthcare Report Q1 2018
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Galenika
Hemofarm (Stada)
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Serbia 2005-2025)
Table: Population By Age Group (Serbia 2005-2025)
Table: Population By Age Group % (Serbia 2005-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report